Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $9.59 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.